Clinical Trial Update: Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) [Phase 2]

View source ↗

Summary

This Phase 2 trial from the University of Manitoba is evaluating antibiotic prophylaxis in patients with myelodysplastic syndrome and acute myeloid leukemia; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Essential Thrombocythemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia
• Polycythemia Vera

Snippet

Sponsor: University of Manitoba | Conditions: Myeldysplastic Syndrome (MDS), MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) | Phase 2 | Status: NOT_YET_RECRUITING